Sarah T Diepstraten

14PUBLICATIONS
67CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsElectrochemical energy storage and conversionHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 18, 2026
A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.

|Aug 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.

Margaret A Potts, Shinsuke Mizutani, Yexuan Deng

|Jan 30, 2025
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.

Wei Jin, Yexuan Deng, John E La Marca

|Dec 14, 2023
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses.

John E La Marca, Brandon J Aubrey, Bruce Yang

|Oct 25, 2023
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells.

Zilu Wang, Matteo Burigotto, Sabrina Ghetti

|Aug 11, 2023
BCL-W makes only minor contributions to MYC-driven lymphoma development.

Sarah T Diepstraten, John E La Marca, Catherine Chang

Pageof 3

Frequent Collaborators

9 joint publications

Andreas Strasser

8 joint publications

Gemma L Kelly

7 joint publications

Marco J Herold

4 joint publications

John E La Marca